Chad M. Robins
CEO and Chairman at Adaptive Biotechnologies Corporation
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Adaptive Biotechnologies Corporation, 3 years.
Adaptive Biotechnologies Corporation
Director · CEO and Chairman
Chief executive roles
Adaptive Biotechnologies Corporation
· CEO and Chairman
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 8, 2026 | Adaptive Biotechnologies Corporation | Open-market sale | −37,263 | $15.19 | $566,025 |
| Apr 6, 2026 | Adaptive Biotechnologies Corporation | Open-market sale | −83,332 | $14.41 | $1,200,814 |
| Mar 11, 2026 | Adaptive Biotechnologies Corporation | Open-market sale | −140,567 | $13.17 | $1,851,267 |
| Mar 11, 2026 | Adaptive Biotechnologies Corporation | Open-market sale | −329,600 | $13.17 | $4,340,832 |
| Mar 6, 2026 | Adaptive Biotechnologies Corporation | Grant or award | +709,220 | — | — |
| Mar 4, 2026 | Adaptive Biotechnologies Corporation | Grant or award | +127,813 | — | — |
| Mar 3, 2026 | Adaptive Biotechnologies Corporation | Open-market sale | −50,703 | $15.49 | $785,389 |
| Mar 3, 2026 | Adaptive Biotechnologies Corporation | Open-market sale | −2,380 | $16.15 | $38,437 |
| Mar 2, 2026 | Adaptive Biotechnologies Corporation | Open-market sale | −289,024 | $15.82 | $4,572,360 |
| Feb 27, 2026 | Adaptive Biotechnologies Corporation | Open-market sale | −182,891 | $15.99 | $2,924,427 |
| Feb 2, 2026 | Adaptive Biotechnologies Corporation | Open-market sale | −124,998 | $18.44 | $2,304,963 |
| Jan 5, 2026 | Adaptive Biotechnologies Corporation | Open-market sale | −124,998 | $15.59 | $1,948,719 |
| Dec 1, 2025 | Adaptive Biotechnologies Corporation | Open-market sale | −124,998 | $18.94 | $2,367,462 |
| Nov 26, 2025 | Adaptive Biotechnologies Corporation | Open-market sale | −35,736 | $19.68 | $703,284 |
| Nov 12, 2025 | Adaptive Biotechnologies Corporation | Open-market sale | −1,867 | $15.00 | $28,005 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.